Skip to main content

Table 4 Estimated increments in each risk variable per 1 standard deviation of ln LAP or ln BMI. Population estimates derived for US adults from NHANES III (1988–1994) with adjustments for sex and race-ethnicity.

From: The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison

Dependent variable Age (years) range Mean outcome value, units Observations (N) used in analyses Increment (SE) per 1 SD in ln LAP Increment (SE) per 1 SD in ln BMI
Total cholesterol 18–49 4.96 mmol/L 5597 0.413 (0.023) 0.225 (0.018)***
  50+ 5.75 mmol/L 3582 0.320 (0.024) 0.089 (0.022)***
HDL cholesterol 18–49 1.29 mmol/L 5571 -0.152 (0.008) -0.111 (0.007)**
  50+ 1.32 mmol/L 3570 -0.187 (0.009) -0.109 (0.010)***
LDL cholesterol 18–49 3.09 mmol/L 3858 0.326 (0.023) 0.220 (0.021)**
  50+ 3.62 mmol/L 2754 0.146 (0.031) 0.058 (0.026)
Total cholesterol/HDL cholest. 18–49 4.16 mmol/L 5570 0.905 (0.040) 0.584 (0.033)***
  50+ 4.74 mmol/L 3570 0.930 (0.042) 0.383 (0.042)***
Apolipo-protein B 18–49 0.97 g/L 2668† 0.123 (0.006) 0.074 (0.007)***
  50+ 1.16 g/L 1807† 0.115 (0.010) 0.056 (0.007)***
ApoB/ApoA1 18–49 0.717 2642† 0.115 (0.006) 0.074 (0.006)***
  50+ 0.810 1801† 0.109 (0.009) 0.069 (0.006)**
LDL cholesterol/ApoB 18–49 3.15 mmol/g 1813† -0.090 (0.017) -0.013 (0.012)**
  50+ 3.19 mmol/g 1393† -0.160 (0.018) -0.066 (0.022)**
Uric acid 18–49 315 μmol/L 5524 27 (1) 25 (1)
  50+ 334 μmol/L 3506 30 (2) 23 (2)*
Systolic blood pressure 18–49 115.1 mm Hg 5594 3.8 (0.2) 3.9 (0.2)
  50+ 134.1 mm Hg 3580 3.1 (0.3) 2.0 (0.4)
Diastolic blood pressure 18–49 72.9 mm Hg 5592 3.7 (0.2) 3.3 (0.2)
  50+ 75.5 mm Hg 3580 2.0 (0.2) 2.0 (0.2)
Heart rate 18–49 73.4 bpm 5482 2.4 (0.3) 1.8 (0.2)
  50+ 74.1 bpm 3493 2.2 (0.3) 1.2 (0.3)
  1. * p < 0.01, ** p < 0.001, *** p < 0.0001, indicating significantly different beta coefficients for ln LAP and ln BMI.
  2. † Lipoprotein data obtained only during phase 1 of NHANES III.
\